+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Allogeneic Stem Cell Therapies, Autologous Stem Cell Therapies), By Therapeutic Application (Oncology), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 5976512
Description Jump to:
The global stem cell therapy market size is estimated to reach at USD 1.67 billion in 2030 and is expected to grow at a CAGR of 25.23% from 2025 to 2030. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spectrum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

Stem Cell Therapy Market Report Highlights

  • Based on the therapy type, the market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapies segment dominated the market with a share of 69.22% in 2024.
  • The autologous stem cell therapy market is witnessing a significant expansion, driven by significant progress in clinical trials and research within the field.
  • Based on therapeutic application, the market is segmented into oncology, cardiovascular disease (CVD), musculoskeletal disorders, and others. The others segment accounted for 72.45% in 2024, fueled by ongoing research and clinical advancements.
  • North America accounted for the largest market share of 50.67% in 2024 and the highest CAGR during the forecast period.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Therapy Type
1.2.2. Therapeutic Application
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing research & development in stem cell therapy
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of stem cell therapy
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Stem Cell Therapy Market: Therapy Type Business Analysis
4.1. Segment Dashboard
4.2. Global Stem Cell Therapy Market Therapy Type Movement Analysis
4.3. Global Stem Cell Therapy Market Size & Trend Analysis, by Therapy Type, 2018 to 2030 (USD Million)
4.4. Allogeneic Stem Cell Therapies
4.4.1. Global Allogeneic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Hematopoietic Stem Cell Therapies
4.4.2.1. Global Hematopoietic Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Mesenchymal Stem Cell Therapies
4.4.3.1. Global Mesenchymal Stem Cell Therapies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Autologous Stem Cell Therapies by Type
4.5.1. Global Autologous Stem Cell Therapies, by Type Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. BM, Blood, & Umbilical Cord-derived Stem Cells
4.5.2.1. Global BM, Blood, & Umbilical Cord-derived Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Adipose-Derived Cells
4.5.3.1. Global Adipose-Derived Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Others
4.5.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Stem Cell Therapy Market: Therapeutic Application Business Analysis
5.1. Segment Dashboard
5.2. Global Stem Cell Therapy Market Therapeutic Application, Movement Analysis
5.3. Global Stem Cell Therapy Market Size & Trend Analysis by Therapeutic Application, 2018 to 2030 (USD Million)
5.4. Oncology
5.4.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease (CVD)
5.5.1. Global Cardiovascular Disease (CVD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Musculoskeletal Disorders
5.6.1. Global Musculoskeletal Disorders Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Stem Cell Therapy Market: Regional Estimates & Trend Analysis by Therapy Type, and Therapeutic Application
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. North America Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Europe Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Switzerland
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. Switzerland Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. South Korea Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Rest of World
6.6.1. Rest of World Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Participant’s Overview
7.4.1. Bluebird Bio, Inc.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. NIPRO
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Kyowa Kirin
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Pharmicell Co., Ltd.
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. CorestemChemon Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. ANTEROGEN.CO.,LTD.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Holostem S.r.l.
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Vertex Pharmaceuticals, Inc.
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Cleveland Cord Blood Center
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Highbridge Capital Management
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 4 Global stem cell therapy market, by application, 2018 - 2030 (USD Million)
Table 5 Global stem cell therapy market, by region, 2018 - 2030 (USD Million)
Table 6 North America stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 7 North America stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 8 North America stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 9 U.S. stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 10 U.S. stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 11 U.S. stem cell therapy market, by end-use, 2018 - 2030 (USD Million)
Table 12 Canada stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 13 Canada stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 14 Europe stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 15 Europe stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 16 Europe stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 17 UK stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 18 UK stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 19 Germany stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 20 Germany stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 21 Switzerland stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 22 Switzerland stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 23 Asia Pacific stem cell therapy market, by country, 2018 - 2030 (USD Million)
Table 24 Asia Pacific stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 25 Asia Pacific stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 26 Japan stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 27 Japan stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 28 China stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 29 China stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 30 India stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 31 India stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 32 South Korea stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 33 South Korea stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 34 Rest of World stem cell therapy market, by therapy type, 2018 - 2030 (USD Million)
Table 35 Rest of World stem cell therapy market, by therapeutical application, 2018 - 2030 (USD Million)
Table 36 Participant's overview
Table 37 Financial performance
Table 38 Key companies undergoing expansions
Table 39 Key companies undergoing acquisitions
Table 40 Key companies undergoing collaborations
Table 41 Key companies launching new products
Table 42 Key companies undertaking other strategies
List of Figures
Fig. 1 Stem cell therapy market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Stem cell therapy market driver analysis
Fig. 12 Stem cell therapy market restraint analysis
Fig. 13 Stem cell therapy market: Porter's analysis
Fig. 14 Stem cell therapy market: PESTEL analysis
Fig. 15 Stem cell therapy market: Therapy type outlook and key takeaways
Fig. 16 Stem cell therapy market: Therapy type market share analysis, 2023 - 2030
Fig. 17 Global stem cell therapy by allogeneic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 18 Global stem cell therapy by hematopoietic stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 19 Global stem cell therapy by mesenchymal stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 20 Global stem cell therapy by autologous stem cell therapies market, 2018 - 2030 (USD Million)
Fig. 21 Global stem cell therapy by BM, blood, & umbilical cord-derived stem cells market, 2018 - 2030 (USD Million)
Fig. 22 Global stem cell therapy by adipose derived cells market, 2018 - 2030 (USD Million)
Fig. 23 Global stem cell therapy by others market, 2018 - 2030 (USD Million)
Fig. 24 Stem cell therapy market: Therapeutical application outlook and key takeaways
Fig. 25 Stem cell therapy market: Therapeutical application market share analysis, 2023-2030
Fig. 26 Global stem cell therapy by oncology market, 2018 - 2030 (USD Million)
Fig. 27 Global stem cell therapy by cardiovascular disease (CVD) market, 2018 - 2030 (USD Million)
Fig. 28 Global stem cell therapy by musculoskeletal disorders market, 2018 - 2030 (USD Million)
Fig. 29 Global stem cell therapy by other market, 2018 - 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Canada stem cell therapy market, 2018 - 2030 (USD Million)
Fig. 34 Europe stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 UK stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Germany stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Switzerland stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Asia-Pacific stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Japan stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 China stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 India stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 South Korea stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Rest of World stem cell therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Key company categorization
Fig. 45 Company market positioning
Fig. 46 Market participant categorization
Fig. 47 Strategy framework

Companies Mentioned

  • Bluebird bio, Inc.
  • NIPRO
  • Kyowa Kirin
  • Pharmicell Co., Ltd.
  • CorestemChemon Inc.
  • ANTEROGEN.CO., LTD.
  • Holostem S.r.l.
  • Vertex Pharmaceuticals, Inc.
  • Cleveland Cord Blood Center
  • Highbridge Capital Management

Methodology

Loading
LOADING...

Related Topics

Related Reports

Stem Cell Therapy Market by Type, Cell Source, Therapeutic Application, End-User - Global Forecast 2025-2030 - Product Image

Stem Cell Therapy Market by Type, Cell Source, Therapeutic Application, End-User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Autologous Stem Cell & Non-Stem Cell Therapies Market by Type, Indication, End-User - Global Forecast 2025-2030 - Product Image

Autologous Stem Cell & Non-Stem Cell Therapies Market by Type, Indication, End-User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029 - Product Image

Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029

  • Report
  • 295 Pages
  • Global
From
Stem Cell Therapy - Global Strategic Business Report - Product Image

Stem Cell Therapy - Global Strategic Business Report

  • Report
  • 78 Pages
  • Global
From
Stem Cell Therapy Global Market Report 2024 - Product Image

Stem Cell Therapy Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.